Related Experiment Video
Updated: Jul 13, 2026

Mechanical Stimulation of Chondrocyte-agarose Hydrogels
Published on: October 27, 2012
Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular
Elena V Tchetina1, John A Di Battista, David J Zukor
1Shriners Hospitals for Children, Department of Surgery, McGill University, 1529 Cedar Avenue, Montreal, Quebec H3G 1A6, Canada.
Abstract:
Suppression of type II collagen (COL2A1) cleavage by transforming growth factor (TGF)-beta2 in cultured human osteoarthritic cartilage has been shown to be associated with decreased expression of collagenases, cytokines, genes associated with chondrocyte hypertrophy, and upregulation of prostaglandin (PG)E2 production. This results in a normalization of chondrocyte phenotypic expression. Here we tested the hypothesis that PGE2 is associated with the suppressive effects of TGF-beta2 in osteoarthritic (OA) cartilage and is itself capable of downregulating collagen cleavage and hypertrophy in human OA articular cartilage. Full-depth explants of human OA knee articular cartilage from arthroplasty were cultured with a wide range of concentrations of exogenous PGE2 (1 pg/ml to 10 ng/ml). COL2A1 cleavage was measured by ELISA. Proteoglycan content was determined by a colorimetric assay. Gene expression studies were performed with real-time PCR. In explants from patients with OA, collagenase-mediated COL2A1 cleavage was frequently downregulated at 10 pg/ml (in the range 1 pg/ml to 10 ng/ml) by PGE2 as well as by 5 ng/ml TGF-beta2. In control OA cultures (no additions) there was an inverse relationship between PGE2 concentration (range 0 to 70 pg/ml) and collagen cleavage. None of these concentrations of added PGE2 inhibited the degradation of proteoglycan (aggrecan). Real-time PCR analysis of articular cartilage from five patients with OA revealed that PGE2 at 10 pg/ml suppressed the expression of matrix metalloproteinase (MMP)-13 and to a smaller extent MMP-1, as well as the proinflammatory cytokines IL-1beta and TNF-alpha and type X collagen (COL10A1), the last of these being a marker of chondrocyte hypertrophy. These studies show that PGE2 at concentrations much lower than those generated in inflammation is often chondroprotective in that it is frequently capable of selectively suppressing the excessive collagenase-mediated COL2A1 cleavage found in OA cartilage. The results also show that chondrocyte hypertrophy in OA articular cartilage is functionally linked to this increased cleavage and is often suppressed by these low concentrations of added PGE2. Together these initial observations reveal the importance of very low concentrations of PGE2 in maintaining a more normal chondrocyte phenotype.
Insights
Prostaglandin E2 (PGE2) at low concentrations can protect against osteoarthritis (OA) by reducing type II collagen (COL2A1) cleavage and chondrocyte hypertrophy in human OA cartilage.
Area of Science:
- Biochemistry
- Cell Biology
- Rheumatology
Background:
- Transforming growth factor (TGF)-beta2 suppresses type II collagen (COL2A1) cleavage in osteoarthritic (OA) cartilage.
- This suppression is linked to altered gene expression and increased prostaglandin E2 (PGE2) production, normalizing chondrocyte phenotype.
- The role of PGE2 in TGF-beta2's suppressive effects and its direct impact on OA cartilage require further investigation.
Purpose of the Study:
- To test the hypothesis that PGE2 is associated with TGF-beta2's suppressive effects in OA cartilage.
- To determine if PGE2 can downregulate collagen cleavage and chondrocyte hypertrophy in human OA articular cartilage.
- To investigate the chondroprotective potential of PGE2 in OA.
Main Methods:
- Human OA knee articular cartilage explants were cultured with varying concentrations of exogenous PGE2 (1 pg/ml to 10 ng/ml).
- COL2A1 cleavage was measured using ELISA, and proteoglycan content was assessed colorimetrically.
- Gene expression of matrix metalloproteinases (MMPs), inflammatory cytokines, and chondrocyte hypertrophy markers was analyzed via real-time PCR.
Main Results:
- PGE2 at 10 pg/ml, similar to TGF-beta2, downregulated collagenase-mediated COL2A1 cleavage in OA cartilage explants.
- PGE2 (10 pg/ml) suppressed the expression of MMP-13, MMP-1, IL-1beta, TNF-alpha, and COL10A1 (a marker of chondrocyte hypertrophy).
- PGE2 did not inhibit proteoglycan (aggrecan) degradation, indicating selective suppression of collagen cleavage and hypertrophy.
Conclusions:
- PGE2, even at concentrations lower than those found during inflammation, demonstrates chondroprotective effects in OA cartilage.
- PGE2 selectively suppresses excessive collagenase-mediated COL2A1 cleavage and chondrocyte hypertrophy in OA.
- Low concentrations of PGE2 are crucial for maintaining a normal chondrocyte phenotype in OA articular cartilage.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...